BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.17.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260703T090000
DTEND;TZID=America/Halifax:20260703T100000
DTSTAMP:20260630T004544Z
CREATED:20260630T004544Z
LAST-MODIFIED:20260630T004544Z
UID:10000775-1783069200-1783072800@oncodaily.com
SUMMARY:Fitness Definition in the Era of VEN Plus HMA Therapy - Resonance
DESCRIPTION:The ALRCaN Global webinar\, “Fitness Definition in the Era of VEN Plus HMA Therapy” is scheduled for Friday\, July 3\, 2026\, from 09:00 AM to 10:00 AM ET. \nPresented by Dr. Adriano Venditti\, this session will explore the evolving definition of fitness in patients receiving venetoclax (VEN) plus hypomethylating agent (HMA) therapy. Organized by the Acute Leukemia Research and Care Network (ALRCaN)\, the webinar is part of the network’s weekly educational series featuring lively discussions on leukemia and supportive care topics. The session is supported by Scott Howard\, Stacy Cooper\, Archie Bleyer\, Dan Douer\, and the Resonance Team.
URL:https://oncodaily.com/event/fitness-529637
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/Hana-7.webp
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260123T090000
DTEND;TZID=America/New_York:20260123T100000
DTSTAMP:20260122T230751Z
CREATED:20260122T230545Z
LAST-MODIFIED:20260122T230751Z
UID:10000615-1769158800-1769162400@oncodaily.com
SUMMARY:Cytopenias Post CAR T-Cells: ALL-Hematotox
DESCRIPTION:The ALRCaN (Acute Leukemia Research and Care Network) webinar\, titled “Cytopenias Post CAR T-Cells: ALL-Hematotox“\, is scheduled for Friday\, January 23\, 2026\, from 09:00 to 10:00 AM ET. \nPresented by Dr. Nirali N. Shah\, this session focuses on the newly developed ALL-Hematotox (ALL-HT) score\, a clinical tool designed to predict hematological toxicity specifically in patients with B-cell acute lymphoblastic leukemia (B-ALL) following CAR T-cell therapy. This weekly collegial gathering\, hosted by Resonance\, allows experts to share best practices and clinical insights to optimize post-infusion care and patient outcomes.
URL:https://oncodaily.com/event/all-hematotox-445445
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/Nirali-Shah.webp
LOCATION:
END:VEVENT
END:VCALENDAR